Observations that p53 C-terminal acetylation enhances neuronal survival yet typically causes tumor cell death led the authors to propose that strategies aimed at promoting p53 acetylation (i.e., HDAC inhibition) might be beneficial for preventing neuronal cell degeneration without compromising tumor suppression [72]. Here, HDAC9 is linked to neoplasm.